Cephea | Design Features and EFS Trial Status

Sunday, March 9, 2025

9:43 AM – 9:51 AM ET

Speaker(s)

Paul Sorajja, MD

Director, Center for Valve and Structural Heart Disease, Minneapolis Heart Institute, Abbott Northwestern Hospital
Allina Health Minneapolis Heart Institute
Minneapolis, Minnesota, United States

Disclosure(s): LAZA: Consulting Fees (e.g., advisory boards) (Ongoing)

Disclosure(s):

Pradeep Yadav, MD: Abbott Labs: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BSCI: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); DASI Simulations: Consulting Fees (e.g., advisory boards) (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Edward Lifesciences: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Excision Medical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); medtronic.: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); PiCardia: Consulting Fees (e.g., advisory boards) (Ongoing); Trisol: Consulting Fees (e.g., advisory boards) (Ongoing)